Cart
sales@molnova.com
CFI-400437 dihydrochloride
CAS No. 1247000-76-5
CFI-400437 dihydrochloride ( —— )
Catalog No. M23418 CAS No. 1247000-76-5
CFI-400437 is a selective and potent polo-like kinase 4 (PLK4) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 237 | In Stock |
|
| 25MG | 484 | In Stock |
|
| 50MG | 699 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 500MG | 1953 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCFI-400437 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCFI-400437 is a selective and potent polo-like kinase 4 (PLK4) inhibitor.
-
DescriptionCFI-400437 is a selective and potent polo-like kinase 4 (PLK4) inhibitor.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPLK
-
RecptorPLK4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1247000-76-5
-
Formula Weight565.5
-
Molecular FormulaC29H30Cl2N6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:5 mM
-
SMILESCN1CCN(CC1)C2=NC=C(C=C2)/C=C/C3=C4C=CC(=CC5=C(NC6=C5C=C(C=C6)OC)O)C=C4N=N3.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Suri A , Bailey A W , Tavares M T , et al. Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer[J]. International Journal of Molecular Sciences, 2019, 20(9).
molnova catalog
related products
-
Pyridoxine
Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body.
-
Rigosertib sodium
Rigosertib sodium (ON 01910.Na) is a potent, non-ATP-competitive PLK1 inhibitor (IC50=9-10 nM).
-
Ilexsaponin A1
Ilexsaponin A shows protective effects on ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.
